Posted on 12/17/20
Why AstraZeneca's and Sanofi's Bad News Could Be Great News for Pfizer and Moderna
It might seem like everything is going well for COVID-19 vaccines right now. The first Americans have already been vaccinated with Pfizer's (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) . . .
Posted on 12/17/20
What Pfizer's Vaccine Authorization Means for Moderna
The U.S. Food and Drug Administration (FDA) granted Pfizer's (NYSE:PFE) coronavirus vaccine candidate Emergency Use Authorization (EUA) last week. On Dec. 17, the FDA will meet . . .
Posted on 12/17/20
Where Will CVS Health Be in 5 Years?
Only five years ago, investors were bidding up shares of CVS Health (NYSE:CVS) as the company took over Target's (NYSE:TGT) pharmacy business and acquired a business . . .
Posted on 12/16/20
Exo Therapeutics Launches with $25 Million Series A Financing
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exo Therapeutics, Inc., a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets, today announced the completion . . .
Posted on 12/16/20
Which Is the Best COVID Vaccine Stock Now: Pfizer, BioNTech, or Moderna?
Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) recently won U.S. emergency use authorization (EUA) for their COVID-19 vaccine. An EUA for Moderna's (NASDAQ:MRNA) vaccine could be only days away. In . . .
Posted on 12/16/20
3 Buffett Stocks to Avoid Like the Plague
Few investors on Wall Street are more influential than Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B) CEO Warren Buffett. That's because almost no one can hold a candle to the . . .
Posted on 12/16/20
Why Moderna Got Slammed on Tuesday
What happenedThere was good news with Moderna (NASDAQ:MRNA) on Tuesday regarding its closely followed mRNA-1273 coronavirus vaccine candidate. However, comments made by a health expert who . . .
Posted on 12/16/20
Arvinas Prices $400M Public Offering of Common Stock
NEW HAVEN, Conn., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted . . .
Posted on 12/16/20
Ocular Therapeutix Prices Public Offering of Common Stock
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the . . .
Posted on 12/16/20
Forma Therapeutics Closes Public Offering
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the closing of an underwritten . . .
Posted on 12/15/20
Radius Health Provides Business Update
WALTHAM, Mass., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS) provided a general business update on progress made since October 2020. The key . . .
Posted on 12/15/20
Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis
BOSTON, Mass., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Yumanity Therapeutics, a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative . . .
Posted on 12/15/20
When Will Pfizer and Moderna Recognize COVID Vaccine Revenue?
Pfizer(NYSE:PFE) and Moderna(NASDAQ:MRNA) are waiting on pins and needles to receive emergency use authorizations (EUA) for their COVID-19 vaccines. And investors are anxiously awaiting the big . . .
Posted on 12/15/20
Here's Why Merck Made a Mistake by Selling Its Moderna Stake
Merck(NYSE:MRK) was one of the earliest investors in Moderna(NASDAQ:MRNA), buying a position in the biotech even before it went public in late 2018. Earlier this month, . . .
Posted on 12/14/20
Arvinas Announces Proposed Offering of Common Stock
NEW HAVEN, Conn., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted . . .
Posted on 12/14/20
Ocular Therapeutix Proposes Public Offering of Common Stock
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the . . .
Posted on 12/14/20
Curis Closes of Public Offering of Common Stock with $169.6 Million in Gross Proceeds
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced the closing of its underwritten . . .
Posted on 12/14/20
The Next Major Pharmaceutical Acquisition Is Here
Summary AstraZeneca has announced its acquiring Alexion at a fairly substantial 45% premium. It's a mixed stock - cash offer.The synergies will cover most of the . . .
Posted on 12/14/20
U.S. Government Orders 100 Million More Doses of Moderna's Coronavirus Vaccine
The pandemic-ravaged U.S. is set to receive an additional 100 million doses of Moderna's (NASDAQ:MRNA) coronavirus vaccine, the company announced after market hours on Friday. The . . .
Posted on 12/14/20
Moderna Investors, Meet Mr. Market
If you had an eccentric friend with a reputation for impulsiveness and hyperbole, you'd definitely think twice before agreeing with their appraisal of their latest obsession, . . .
Posted on 12/14/20
Why Berkshire Hathaway Is a Retiree's Dream Stock
There's no denying that the past couple of years have been relatively disappointing ones for Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) shareholders. Stock in the Warren Buffett-led multinational . . .
Posted on 12/14/20
Where Will Moderna Be in 5 Years?
Can you name a company that's developing drugs for rare inherited illnesses, blocked arteries, and vaccines for infectious diseases you've never heard of? Since you clicked . . .
Posted on 12/14/20
Why Did This Big Investor Sell Its Moderna Stock?
Merck (NYSE:MRK) had been an investor in Moderna(NASDAQ:MRNA) since before the biotech had its initial public offering. But the big pharma recently disclosed that it sold . . .
Posted on 12/14/20
How Many COVID Vaccine Doses Will Pfizer and Moderna Distribute by Year-End?
Good news could be right around the corner. Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) hope to soon win FDA emergency use authorizations (EUA) for their respective COVID-19 . . .
Posted on 12/14/20
Buy, Sell, or Hold Moderna Stock at an All-Time High?
Now that Pfizer's (NYSE:PFE) COVID vaccine has received emergency use authorization in the U.K., Canada, and the U.S., all eyes are on Moderna's (NASDAQ:MRNA) candidate to . . .
Boston
